Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 8, 2004, Pages 512-517

  Lax, Clare J ^a   Domenighetii, Andrea A ^a,b   Pavia, Jillian M ^a   Di Nicolantonio, Robert ^a   Curl, Claire L ^a   Morris, Margaret J ^a   Delbridge, Lea M D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Angiotensin II; AT1 AT2 receptors; Cardiac hypertrophy; Cardiac remodelling; Myocardial infarction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEART INFARCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE WALL; HEART MUSCLE; HEART RIGHT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART WEIGHT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

ANIMALS; DOWN-REGULATION; GENE EXPRESSION REGULATION; MYOCARDIAL INFARCTION; MYOCARDIUM; POSTOPERATIVE PERIOD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 2; TIME FACTORS; VENTRICULAR REMODELING;

EID: 4143147340     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04034.x     Document Type: Article

References (45)

1. Pfeffer MA, Braunwald E. Ventricular remodelling after myocardial infarction. Circulation 1990; 81: 1161-72.
2. Cohn JN, Ferrari R, Sharpe N. Cardiac remodelling concepts and clinical implications: A consensus paper from an international forum on cardiac remodelling. On Behalf of an International Forum on Cardiac Remodelling. J. Am. Coll. Cardiol. 2000; 35: 569-82.
3. Pfeffer JM, Fissher TA, Pfeffer MA. Angiotensin converting enzyme inhibition and ventricular remodelling after myocardial infarction. Annu. Rev. Physiol. 1995; 57: 805-26.
4. Timmermans PB, Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonist. Pharmacol. Rev. 1993; 45: 205-51.
5. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am. J. Physiol. 1990; 259: H610-18.
6. 1 receptor subtype. Circ. Res. 1993; 73: 413-23.
7. Liu Y, Leri A, Li B et al. Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes. Circ. Res. 1998; 82: 1145-59.
8. Ritchie RH, Schiebinger RJ, LaPointe MC, Marsh JD. Angiotensin II-induced hypertrophy of adult rat cardiocytes is blocked by nitric oxide. Am. J. Physiol. 1998; 275: H1370-4.
9. Crabos M, Roth M, Hahn AW, Erne P. Characterisation of angiotensin II receptors in cultured adult rat cardiac fibroblasts: Coupling to signalling systems and gene expression. J. Clin. Invest. 1994; 93: 2372-8.
10. Lindpaintner K, Lu W, Niedermajer N et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodelling in the rat. J. Mol. Cell. Cardiol. 1993; 25: 133-43.
11. Falkenhahn M, Franke F, Bohle RM et al. Cellular distribution of angiotensin converting enzyme after myocardial infarction. Hypertension 1995; 25: 219-26.
12. Passier RCJJ, Smits JFM, Verluyten MJA, Daemen MJAP. Expression and localisation of renin and angiotensinogen in rat heart after myocardial infarction. Am. J. Physiol. 1996; 271: H1040-8.
13. Hirsch AT, Opsahl JA, Lunzer MM, Katz SA. Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction. Am. J. Physiol. 1999; 276: H1818-26.
14. Weber KT, Sun Y. Recruitable ACE and tissue repair in the infarcted heart. J. Renin Angiotensin Aldosterone Syst. 2000; 1: 295-303.
15. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G. ACE inhibitor use in patients with myocardial infarction: Summary of evidence from clinical trials. Circulation 1995; 92: 3132-7.
16. Schieffer B, Wirger A, Meybrunn M et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin type 1 receptor blockade on cardiac remodelling after myocardial infarction in the rat. Circulation 1994; 89: 2273-82.
17. Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J. Clin. Invest. 1997; 99: 1926-35.
18. 1 receptor blockade in rats with myocardial infarction-induced heart failure. Cardiovasc. Res. 2001; 49: 110-17.
19. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am. J. Cardiol. 2002; 89: A3-9.
20. Nio Y, Matsubara S, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J. Clin. Invest. 1995; 95: 46-54.
21. Zhu YZ, Zhu YC, Li J et al. Effects of Iosartan on haemodynamrc parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction. J. Renin Angiotensin Aldosterone Syst. 2000; 1: 257-62.
22. Meggs LG, Coupet J, Huang H et al. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ. Res. 1993; 72: 1149-62.
23. Yang B, Li D, Phillips MI, Mehta P, Mehta JL. Myocardial angiotensin II receptor expression and ischaemia-reperfttsion injury. Vasc. Med. 1998; 3: 121-30.
24. 1 receptor expression after myocardial infarction in rats. Chin. Med. J. 1999; 112: 593-6.
25. Lefroy DC, Wharton J, Crake T et al. Regional changes in angiotensin II receptor density after experimental myocardial infarction. J. Mol. Cell. Cardiol. 1996; 28: 429-40.
26. Tsutsumi Y, Matsubara H, Ohkubo N et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ. Res. 1998; 83: 1035-46.
27. Regitz-Zagrosek V, Friedel N, Heymann A et al. Regulation, chamber localisation, and subtype distribution of angiotensin II receptors in human hearts. Circulation 1995; 91: 1461-71.
28. 1-receptor subtype in failing human ventricular myocardium. Circulation 1997; 95: 1193-200.
29. 2 angiotensin receptor gene expression in human heart failure. Circulation 1997; 95: 1201-6.
30. 1 receptor density in the failing human heart. Circulation 1998; 98: 1735-41.
31. Burrell LM, Chan R, Phillips P, Calafiore P, Tonkin A, Johnston CI. Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the rat. Clin. Exp. Pharmacol. Physiol. 1996; 23: 570-2.
32. Kompa AR, Summers RJ. Lidocaine and surgical modification reduces mortality in a rat model of cardiac failure induced by coronary artery ligation. J. Pharmacol. Toxicol. Methods 2000; 43: 199-203.
33. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: Pitfalls and potential. Biotechniques 1999; 26: 112-25.
34. Southern EM. Measurement of DNA length by gel electrophoresis. Anal. Biochem. 1979; 100: 319-23.
35. Schaffer HE, Sederoff RR. Improved estimation of DNA length from agarose gels. Anal. Biochem. 1981; 115: 113-22.
36. 1 antagonists on mice. Hypertension 2002; 40: 244-50.
37. 2 receptors in cardiac hypertrophy and cardiac remodelling. Clin. Exp. Pharmacol. Physiol. 2003; 30: 911-18.
38. Ichiki T, Labosky PA, Shiota C et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-50.
39. Ito M, Oliverio MI, Mannon PJ et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc. Natl Acad. Sci. USA 1995; 92: 3521-5.
40. Tsuzuki S, Matoba T, Eguchi S, Inagami T. Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase. Hypertension 1996; 28: 916-18.
41. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 1995; 377: 744-7.
42. Adachi Y, Saito Y, Kishimoto I et al. Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 2003; 107: 2406-8.
43. Yang Z, Bove CM, French BA et al. Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation 2002; 106: 106-11.
44. Ichihara S, Senbonmatsu T, Price Jr E, Ichiki T, Gaffney FA, Inagami T. Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction. Circulation 2002; 106: 2167-9.
45. Schuijt MP, Basdew M, van Veghel R et al. AT(2) receptor-mediated vasodilation in the heart: Effect of myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2001; 281: H2590-6.